Pregnant users turn to cannabis for mood relief, real-time study shows

This groundbreaking ecological momentary assessment study provides the first real-time evidence that pregnant individuals use cannabis to manage negative emotions like anxiety, depression, and irritability. Researchers followed 20 pregnant participants (average 22.5 weeks gestation) over a 14-day period, collecting data on mood and cannabis use across an average of nearly 15 use events per person. The findings reveal a clear bidirectional relationship: higher levels of momentary negative affect predicted increased likelihood of cannabis use, suggesting that emotional regulation drives prenatal cannabis consumption.

The research also demonstrates that cannabis use itself produces short-term relief from depression, anxiety, and irritability, creating a potential reinforcement cycle. After consuming cannabis, participants reported measurable reductions in all three forms of negative affect, supporting what researchers call the affect regulation hypothesis—the idea that people use cannabis specifically to manage difficult emotions. This short-term mood improvement may encourage repeated use, establishing a pattern where relief from emotional distress becomes the primary driver of continued prenatal cannabis consumption.

These findings carry significant clinical implications, as they identify a key mechanism maintaining prenatal cannabis use during a critical period of fetal development. Understanding that mood regulation motivates cannabis use in pregnancy opens pathways for targeted mental health interventions. Rather than simply discouraging use, healthcare providers may need to address underlying anxiety and depression through evidence-based treatments, offering pregnant individuals healthier alternatives for managing negative emotions. The study highlights the urgent need for comprehensive prenatal mental health screening and support to reduce cannabis use during pregnancy."